BINEX Co. Ltd (053030) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, BINEX Co. Ltd (053030) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩3.62 Billion ≈ $2.45 Million USD) by net assets (₩187.21 Billion ≈ $126.87 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 053030 market cap for the company's overall valuation and market capitalisation.

BINEX Co. Ltd - Cash Flow Conversion Efficiency Trend (2005–2024)

This chart illustrates how BINEX Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

BINEX Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of BINEX Co. Ltd ranked by their cash flow conversion efficiency. Explore how high is BINEX Co. Ltd's earnings quality to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
ROKISKIO SURIS PC EO 029
F:YTV
N/A
China Automotive Systems Inc
NASDAQ:CAAS
0.069x
Purple Capital Ltd
JSE:PPE
0.014x
KNOTUS Co.Ltd
KQ:278650
-0.083x
Paramita Bangun Sarana Tbk PT
JK:PBSA
0.083x
Lastminute.com NV
F:09B
-0.327x
Rhinebeck Bancorp Inc
NASDAQ:RBKB
0.020x
NINtec Systems Limited
NSE:NINSYS
0.151x

Annual Cash Flow Conversion Efficiency for BINEX Co. Ltd (2005–2024)

The table below shows the annual cash flow conversion efficiency of BINEX Co. Ltd from 2005 to 2024. View latest BINEX Co. Ltd stock price today for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩181.61 Billion
≈ $123.07 Million
₩-9.43 Billion
≈ $-6.39 Million
-0.052x -349.11%
2023-12-31 ₩181.33 Billion
≈ $122.88 Million
₩3.78 Billion
≈ $2.56 Million
0.021x -76.60%
2022-12-31 ₩191.61 Billion
≈ $129.85 Million
₩17.06 Billion
≈ $11.56 Million
0.089x -42.77%
2021-12-31 ₩180.42 Billion
≈ $122.27 Million
₩28.07 Billion
≈ $19.02 Million
0.156x +35.30%
2020-12-31 ₩173.22 Billion
≈ $117.39 Million
₩19.92 Billion
≈ $13.50 Million
0.115x +71.13%
2019-12-31 ₩160.50 Billion
≈ $108.77 Million
₩10.78 Billion
≈ $7.31 Million
0.067x -25.95%
2018-12-31 ₩149.43 Billion
≈ $101.27 Million
₩13.56 Billion
≈ $9.19 Million
0.091x +43.61%
2017-12-31 ₩128.75 Billion
≈ $87.25 Million
₩8.14 Billion
≈ $5.51 Million
0.063x +133.80%
2016-12-31 ₩140.55 Billion
≈ $95.25 Million
₩3.80 Billion
≈ $2.57 Million
0.027x +186.63%
2015-12-31 ₩144.14 Billion
≈ $97.68 Million
₩-4.50 Billion
≈ $-3.05 Million
-0.031x -64.56%
2013-12-31 ₩97.45 Billion
≈ $66.04 Million
₩-1.85 Billion
≈ $-1.25 Million
-0.019x -206.41%
2011-12-31 ₩70.58 Billion
≈ $47.83 Million
₩1.26 Billion
≈ $852.26K
0.018x -80.30%
2007-12-31 ₩34.50 Billion
≈ $23.38 Million
₩3.12 Billion
≈ $2.11 Million
0.090x +14.74%
2006-12-31 ₩31.91 Billion
≈ $21.62 Million
₩2.52 Billion
≈ $1.70 Million
0.079x +54.89%
2005-12-31 ₩28.99 Billion
≈ $19.64 Million
₩1.48 Billion
≈ $999.86K
0.051x --

About BINEX Co. Ltd

KQ:053030 Korea Pharmaceuticals
Market Cap
$143.30 Million
₩211.45 Billion KRW
Market Cap Rank
#17946 Global
#771 in Korea
Share Price
₩6780.00
Change (1 day)
+1.19%
52-Week Range
₩5940.00 - ₩18490.00
All Time High
₩36100.00
About

BINEX Co., Ltd. operates as a pharmaceutical company in South Korea. It offers bisroot products; GI tract and antispasmodic, and antiulcer agents; NSAIDs; cardiovascular and urology products; hepatic protectors; ointments and creams; ophthalmic solutions; CNS agents; digestive products; constipation and blood circulation products; antibiotic and antifungal agents; cough and cold remedy products; … Read more